ANNIE PERNG: Open Payments
NPI 1497261820 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 9 payments from 5 companies in 2025. Trend: 2023 $851 · 2024 $503 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $503 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Gilead Sciences, Inc. | 1 | $110 |
| Cipher Pharmaceuticals US LLC | 1 | $55 |
Products named: ONPATTRO, BREZTRI, FASENRA, Yeztugo, Natroba.
Industry payments across PA — which companies pay providers there.
